Study on Trabectedin in Advanced Rearranged Mesenchymal Chondrosarcoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Mesenchymal Chondrosarcoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Nuovo Ospedale di Prato, Prato, Firenze, Italy
Contact: Study coordinator (Giacomo G. Baldi, MD) · giacomogiulio.baldi@uslcentro.toscana.it · 0039057443
Contact: Principal Investigator (Giacomo G. Baldi, MD)
Policlinico Universitario Campus Biomedico, Roma, RM, Italy
Contact: Study coordinator (Bruno Vincenzi, MD) · b.vincenzi@unicampus.it · 003906-22541
Contact: Principal Investigator (Bruno Vincenzi, MD)
Fondazione del Piemonte per l'Oncologia IRCC Candiolo, Candiolo, Torino, Italy
Contact: Study coordinator (Sandra Aliberti, MD) · sandra.aliberti@ircc.it · 0039-011-993
Contact: Principal Investigator (Giovanni Grignani, MD)
Istituto Ortopedico Rizzoli - Unit of Chemotherapy of Muscoloskeletal Tumors, Bologna, Italy
Contact: Study coordinator (Toni Ibrahim, MD) · toni.ibrahim@ior.it · +390516366
Contact: Principal Investigator (Toni Ibrahim, MD)
Fondazione IRCSS Istituto Nazionale dei Tumori, Milan, Italy
Contact: Study coordinator (Silvia Stacchiotti, MD) · silvia.stacchiotti@istitutotumori.mi.it · +39022390
Contact: Principal Investigator (Silvia Stacchiotti, MD)
Ospedale Giaccone, Palermo, Italy
Contact: Study coordinator (Giuseppe Badalamenti, MD) · giuseppe.badalamenti@unipa.it
Contact: Principal Investigator (Giuseppe Badalamenti, MD)
Istituti Fisioterapici Ospitalieri - Ospedale Regina Elena, Roma, Italy
Contact: Study coordinator (Virginia Ferraresi, MD) · virginia.ferraresi@ifo.it

Study leads

Silvia Stacchiotti, MD
Principal Investigator
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano

View source on ClinicalTrials.gov Contact study team (email)